Anti-interleukin-6 monoclonal antibody for cytokine storm in COVID-19

Novel coronavirus disease 2019 (COVID-19) is known to cause severe pneumonia and acute respiratory distress syndrome which may lead to death. Several treatments have been tested in the race to find a treatment regimen for this deadly viral infection. Tocilizumab, a recombinant humanized anti-interle...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Steven Douedi, Moiuz Chaudhri, Jeffrey Miskoff
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Wolters Kluwer Medknow Publications 2020-01-01
Cyfres:Annals of Thoracic Medicine
Pynciau:
covid-19
cytokine
interleukin-6
infection
monoclonal antibody
tocilizumab
Mynediad Ar-lein:http://www.thoracicmedicine.org/article.asp?issn=1817-1737;year=2020;volume=15;issue=3;spage=171;epage=173;aulast=Douedi
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg